至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Rational design of a DNA-launched live attenuated vaccine against human enterovirus 71

VIROLOGICA SINICA. 2024-09; 
Rong-Rong Zhang 1, Meng-Jiao He 1, Chao Zhou 1, Yan-Peng Xu 1, Wei Tang 1, Tian-Shu Cao 1, Zheng-Jian Wang , Mei Wu , Tao Ming , Yi-Jiao Huang , Meng-Xu Sun , Hui Zhao , Yong-Qiang Deng , Xiao-Feng Li , Bin Wang , Qing Ye , Cheng-Feng Qin
Products/Services Used Details Operation
Peptide Tools Intracellular cytokine staining was employed to quantify EV71 antigen-specific T cells in immunized mice. Briefly, a total of 1,000,000 mouse splenocytes were co-stimulated with an overlapping VP1 peptide pool (1.5 μg/mL for each peptide, GenScript) for 1 hour at 37 °C in the presence of 5% CO2 along with anti-mouse CD28 antibody (Biolegend) and CD49d antibody (Biolegend), both at a concentration of 1 μg/mL. Get A Quote

摘要

Human Enterovirus 71 (EV71) has emerged as one of the predominant causative agents of hand, foot and mouth disease (HFMD) with global impact. Despite the inactivated vaccine being licensed, other vaccine candidates based on advanced technology platforms are under development. In this report, we rationally designed and constructed two DNA-launched live attenuated vaccine candidates (pDL-EV71) under the control of specific promoters. In vitro and in vivo transfection with pDL-EV71 driven by the CMV promoter successfully yielded fully infectious EV71. More importantly, the administration of pDL-EV71 did not cause clinical symptoms following intracranial or intramuscular inoculation in neonatal and IFNα/βR-/- mic... More

关键词